SDEV
Price:
$0.8682
Market Cap:
$43.80M
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Industry
Medical - Pharmaceuticals
IPO Date
2007-10-26
Stock Exchange
NYSE
Ticker
SDEV
According to NovaBay Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.15. This represents a change of 13.00% compared to the average of -0.13 of the last 4 quarters.
The mean historical PE Ratio of NovaBay Pharmaceuticals, Inc. over the last ten years is -0.01. The current -0.15 PE Ratio has changed 129.79% with respect to the historical average. Over the past ten years (40 quarters), SDEV's PE Ratio was at its highest in in the March 2026 quarter at 0.02. The PE Ratio was at its lowest in in the September 2025 quarter at -0.28.
Average
-0.01
Median
-0.00
Minimum
-0.10
Maximum
-0.00
Discovering the peaks and valleys of NovaBay Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.24%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -88.51%
Minimum Annual PE Ratio = -0.10
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.01 | -88.51% |
| 2024 | -0.10 | 4.24% |
| 2023 | -0.00 | 221.40% |
| 2022 | -0.00 | -47.94% |
| 2021 | -0.00 | 109.42% |
| 2020 | -0.00 | 53.97% |
| 2019 | -0.00 | -20.18% |
| 2018 | -0.00 | 24.10% |
| 2017 | -0.00 | 191.67% |
| 2016 | -0.00 | 387.14% |
The current PE Ratio of NovaBay Pharmaceuticals, Inc. (SDEV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.04
5-year avg
-0.02
10-year avg
-0.01
NovaBay Pharmaceuticals, Inc.’s PE Ratio is
| Company | PE Ratio | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBay Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NovaBay Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is NovaBay Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for NovaBay Pharmaceuticals, Inc. (SDEV)?
What is the highest PE Ratio for NovaBay Pharmaceuticals, Inc. (SDEV)?
What is the 3-year average PE Ratio for NovaBay Pharmaceuticals, Inc. (SDEV)?
What is the 5-year average PE Ratio for NovaBay Pharmaceuticals, Inc. (SDEV)?
How does the current PE Ratio for NovaBay Pharmaceuticals, Inc. (SDEV) compare to its historical average?